PubRank

Fabio Caputo

Author PubWeight™ 28.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007 3.62
2 Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 2006 2.55
3 Liver transplantation for patients with alcoholic liver disease: an open question. Dig Liver Dis 2011 2.14
4 Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 2002 2.01
5 Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 2011 1.98
6 Regional cerebral hypoperfusion in patients with celiac disease. Am J Med 2004 1.03
7 Alcohol use in adults. N Engl J Med 2013 0.99
8 Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 2002 0.98
9 Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin Neuropharmacol 2003 0.94
10 The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert Opin Investig Drugs 2009 0.92
11 Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease. Hum Psychopharmacol 2011 0.91
12 Alcohol misuse and traffic accidents. Lancet 2007 0.84
13 Baclofen for outpatient treatment of alcohol withdrawal syndrome. J Fam Pract 2005 0.81
14 Identification and management of alcohol withdrawal syndrome. Drugs 2015 0.81
15 Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention. Expert Opin Pharmacother 2013 0.79
16 Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: risk of severe events are avoided by the dose fractioning of the drug. J Clin Psychopharmacol 2007 0.78
17 GABAB Agonists for the Treatment of Alcohol Use Disorder. Curr Pharm Des 2015 0.78
18 Tolerance to baclofen's sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence. Psychopharmacology (Berl) 2004 0.77
19 Treatment of narcolepsy with cataplexy. Lancet 2007 0.76
20 Treatment of alcohol-use disorders. Lancet 2009 0.76
21 Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report. J Clin Psychopharmacol 2011 0.75
22 Cholesterol lowering in patients with CHD and metabolic syndrome. Lancet 2007 0.75
23 Gamma-hydroxybutyrate as a treatment for alcoholism. Lancet 2005 0.75
24 Baclofen use in the treatment of alcohol delirium tremens. Arch Intern Med 2005 0.75
25 An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned. J Clin Gastroenterol 2010 0.75
26 GABAergic medications for treating alcohol dependence. J Clin Psychopharmacol 2007 0.75
27 Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau. J Crohns Colitis 2011 0.75